Association between N-terminal pro-brain natriuretic peptide and acute ischemic stroke in patients on chronic hemodialysis

International Urology and Nephrology

Volumn 42, Issue 2, 2010, Pages 537-543

  Kim, Yong Kyun ^a   Shin, Seok Joon ^a   Ihm, Sang Hyun ^a   Park, Chan Seok ^a   Kim, Hee Yeol ^a   Kim, Young Du ^a   Shim, Dong Suk ^a   Song, Ho Cheol ^b   Yang, Chul Woo ^a   Kim, Yong Soo ^a   Choi, Euy Jin ^a  

^a The Catholic University of Korea   (South Korea)

^b NONE

Author keywords

Hemodialysis; Left ventricular fractional shortening; Left ventricular mass index; N terminal pro brain natriuretic peptide; Stroke

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; ADULT; ARTICLE; BRAIN ISCHEMIA; CHRONIC PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR;

ACUTE DISEASE; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; STROKE;

EID: 77956186572     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9689-8     Document Type: Article

References (27)

1. Hall C (2004) Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6:257-260
2. Bruneau BG, Piazza LA, de Bold AJ (1997) BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 273: H2678-H2686
3. McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ et al (2001) Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86:21-26
4. Wallen T, Landahl S, Hender T, Nakao K, Saito Y (1997) Brain natriuretic peptide predicts mortality in the elderly. Heart 77:264-267
5. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P (2005) N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293:1609-1616
6. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T et al (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655-663
7. Takahashi T, Nakamura M, Onoda T, Ohsawa M, Tanno K, Itai K et al. (2009) Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Atherosclerosis. doi:10.1016/j. atherosclerosis. 2009.04.029
8. Satyan S, Light RP, Agarwal R (2007) Relationships of Nterminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 50:1009-1019
9. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP et al (2006) Raised plasma N-terminal pro-Btype natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart 92:1518-1519
10. Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E et al (2007) Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 37:350-356
11. Apple FS, Murakami MM, Pearce LA, Herzog CA (2004) Multi-biomarker risk stratification of N-terminal pro-Btype natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50:2279-2285
12. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A et al (2001) Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12:1508-1515
13. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D (2007) N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 71:548-554
14. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA 274:1017-1025
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2:358-367
16. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH (1994) Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23:600-606
17. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH et al (1994) Assessment of left ventricular function by the midwall fractional shortening/ end-systolic stress relation in human hypertension. J Am Coll Cardiol 23:1444-1451
18. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T et al (2005) Practice guidelines of the European society of hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697-701
19. Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK et al (2006) Hemodialysis (HEMO) Study Group. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 47:131-138
20. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO (2003) Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 14:2623-2631
21. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A et al (2002) Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 13: 1918-1927
22. Krane V, Krieter DH, Olschewski M, März W, Mann JF, Ritz E et al (2007) Wanner C. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49:267-275
23. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM et al (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32:2575-2579
24. Chou CY, Kuo HL, Lin HH, Liu JS, Liu YL, Huang CC (2009) C-reactive protein predicts ischaemic stroke in haemodialysis patients. Int J Clin Pract 63:243-248
25. Yukiiri K, Hosomi N, Naya T, Takahashi T, Ohkita H, Mukai M et al (2008) Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke. BMC Neurol 8:45
26. National Institutes of Health, USRDS (2005) 2005 annual data report, Bethesda, MD, p 182
27. Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S et al (2005) Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 45:1058-1066